普瑞巴林 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "普瑞巴林" in Chinese language version.

refsWebsite

Global rank Chinese rank

16doi.org

2^nd place

23^rd place

15nih.gov

4^th place

5^th place

11web.archive.org

1^st place

6semanticscholar.org

11^th place

332^nd place

3books.google.com

3^rd place

8^th place

2europa.eu

68^th place

209^th place

2archive.org

6^th place

4^th place

2scholar.google.com

1,697^th place

3,337^th place

1tga.gov.au

3,984^th place

1,603^rd place

1medicines.org.uk

3,823^rd place

3,456^th place

1clevelandclinicmeded.com

low place

1drugs.com

399^th place

208^th place

1psu.edu

207^th place

628^th place

1wenzhou.gov.cn

low place

7,214^th place

archive.org

Bryans JS, Wustrow DJ. 3-substituted GABA analogs with central nervous system activity: a review. Medicinal Research Reviews. March 1999, 19 (2): 149–177. PMID 10189176. S2CID 38496241. doi:10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B.
Baselt RC. Disposition of Toxic Drugs and Chemicals in Man 8th. Biomedical Publications. 2008: 1296–1297. ISBN 978-0-9626523-7-0.

books.google.com

Benzon HM, Rathmell JP, Wu CL, Turk DC, Argoff CE, Hurley RW. Practical Management of Pain. Elsevier Health Sciences. September 11, 2013: 1006. ISBN 978-0-323-17080-2.
Lin GQ, You QD, Cheng JF (编). Chiral Drugs: Chemistry and Biological Action. John Wiley & Sons. August 8, 2011: 88 [August 17, 2016]. ISBN 9781118075630. （原始内容存档于April 25, 2022） –通过Google Books.
McMahon SB. Wall and Melzack's textbook of pain 6th. Philadelphia, PA: Elsevier/Saunders. 2013: 515. ISBN 9780702040597.

clevelandclinicmeded.com

Pharmacotherapy Update - Pregabalin (Lyrica®):Part I. [2016-02-22]. （原始内容存档于2017-02-27）.

doi.org

Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern?. CNS Drugs. June 2014, 28 (6): 491–496. PMID 24760436. doi:10.1007/s40263-014-0164-4 .
Frampton, JE. Pregabalin: a review of its use in adults with generalized anxiety disorder.. CNS Drugs. September 2014, 28 (9): 835–54. PMID 25149863. doi:10.1007/s40263-014-0192-0.
Bryans JS, Wustrow DJ. 3-substituted GABA analogs with central nervous system activity: a review. Medicinal Research Reviews. March 1999, 19 (2): 149–177. PMID 10189176. S2CID 38496241. doi:10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B.
Calandre EP, Rico-Villademoros F, Slim M. Alpha₂delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Review of Neurotherapeutics. November 2016, 16 (11): 1263–1277. PMID 27345098. S2CID 33200190. doi:10.1080/14737175.2016.1202764.
Uchitel OD, Di Guilmi MN, Urbano FJ, Gonzalez-Inchauspe C. Acute modulation of calcium currents and synaptic transmission by gabapentinoids. Channels. 2010, 4 (6): 490–496. PMID 21150315. doi:10.4161/chan.4.6.12864 .
Sills GJ. The mechanisms of action of gabapentin and pregabalin. Current Opinion in Pharmacology. February 2006, 6 (1): 108–113. PMID 16376147. doi:10.1016/j.coph.2005.11.003.
Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, et al. Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits. European Journal of Pharmacology. September 2011, 667 (1–3): 80–90 [October 20, 2020]. PMID 21651903. doi:10.1016/j.ejphar.2011.05.054. （原始内容存档于October 21, 2020）.
Sze PY. L-Glutamate Decarboxylase. GABA—Biochemistry and CNS Functions. Advances in Experimental Medicine and Biology 123. 1979: 59–78. ISBN 978-1-4899-5201-1. PMID 390996. doi:10.1007/978-1-4899-5199-1_4.
Stahl SM, Porreca F, Taylor CP, Cheung R, Thorpe AJ, Clair A. The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?. Trends in Pharmacological Sciences. June 2013, 34 (6): 332–339. PMID 23642658. doi:10.1016/j.tips.2013.04.001.
Baidya DK, Agarwal A, Khanna P, Arora MK. Pregabalin in acute and chronic pain. Journal of Anaesthesiology Clinical Pharmacology. July 2011, 27 (3): 307–314. PMC 3161452 . PMID 21897498. doi:10.4103/0970-9185.83672 .
Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Research. February 2007, 73 (2): 137–150 [October 19, 2020]. PMID 17126531. S2CID 54254671. doi:10.1016/j.eplepsyres.2006.09.008. （原始内容存档于October 23, 2020）.
Lauria-Horner BA, Pohl RB. Pregabalin: a new anxiolytic. Expert Opinion on Investigational Drugs. April 2003, 12 (4): 663–672. PMID 12665421. S2CID 36137322. doi:10.1517/13543784.12.4.663.
Desai A, Kherallah Y, Szabo C, Marawar R. Gabapentin or pregabalin induced myoclonus: A case series and literature review. Journal of Clinical Neuroscience. 2019-03, 61: 225–234. PMID 30381161. S2CID 53165515. doi:10.1016/j.jocn.2018.09.019.
Tanyıldız B, Kandemir B, Mangan MS, Tangılntız A, Göktaş E, Şimşek S. Bilateral Serous Macular Detachment After Attempted Suicide with Pregabalin. Turkish Journal of Ophthalmology. 2018-10, 48 (5): 254–257. PMC 6216534 . PMID 30405948. doi:10.4274/tjo.70923.
Murphy NG, Mosher L. 79. Severe myoclonus from pregabalin (Lyrica) due to chronic renal insufficiency. Clinical Toxicology. 2008, 46 (7): 604. S2CID 218857181. doi:10.1080/15563650802255033 .
Yoo L, Matalon D, Hoffman RS, Goldfarb DS. Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure (PDF). American Journal of Kidney Diseases. 2009-12, 54 (6): 1127–1130 [October 19, 2020]. CiteSeerX 10.1.1.955.4223 . PMID 19493601. doi:10.1053/j.ajkd.2009.04.014. （原始内容存档于2022-04-12）.

drugs.com

Pregabalin. The American Society of Health-System Pharmacists. [2015-10-23]. （原始内容存档于2020-08-09）.

europa.eu

ema.europa.eu

Lyrica EPAR. European Medicines Agency (EMA). 2004-07-06 [2023-12-21]. （原始内容存档于2023-12-21）.
Summary of product characteristics (PDF). European Medicines Agency. 2013-03-06 [2013-05-06]. （原始内容存档 (PDF)于2018-09-16）.

medicines.org.uk

Lyrica Summary of Product Characteristics (SmPC). (emc). 2023-02-27 [2023-12-21]. （原始内容存档于2023-12-21）.

nih.gov

ncbi.nlm.nih.gov

Schifano F. Misuse and abuse of pregabalin and gabapentin: cause for concern?. CNS Drugs. June 2014, 28 (6): 491–496. PMID 24760436. doi:10.1007/s40263-014-0164-4 .
Frampton, JE. Pregabalin: a review of its use in adults with generalized anxiety disorder.. CNS Drugs. September 2014, 28 (9): 835–54. PMID 25149863. doi:10.1007/s40263-014-0192-0.
Bryans JS, Wustrow DJ. 3-substituted GABA analogs with central nervous system activity: a review. Medicinal Research Reviews. March 1999, 19 (2): 149–177. PMID 10189176. S2CID 38496241. doi:10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B.
Calandre EP, Rico-Villademoros F, Slim M. Alpha₂delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Review of Neurotherapeutics. November 2016, 16 (11): 1263–1277. PMID 27345098. S2CID 33200190. doi:10.1080/14737175.2016.1202764.
Uchitel OD, Di Guilmi MN, Urbano FJ, Gonzalez-Inchauspe C. Acute modulation of calcium currents and synaptic transmission by gabapentinoids. Channels. 2010, 4 (6): 490–496. PMID 21150315. doi:10.4161/chan.4.6.12864 .
Sills GJ. The mechanisms of action of gabapentin and pregabalin. Current Opinion in Pharmacology. February 2006, 6 (1): 108–113. PMID 16376147. doi:10.1016/j.coph.2005.11.003.
Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, et al. Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits. European Journal of Pharmacology. September 2011, 667 (1–3): 80–90 [October 20, 2020]. PMID 21651903. doi:10.1016/j.ejphar.2011.05.054. （原始内容存档于October 21, 2020）.
Sze PY. L-Glutamate Decarboxylase. GABA—Biochemistry and CNS Functions. Advances in Experimental Medicine and Biology 123. 1979: 59–78. ISBN 978-1-4899-5201-1. PMID 390996. doi:10.1007/978-1-4899-5199-1_4.
Stahl SM, Porreca F, Taylor CP, Cheung R, Thorpe AJ, Clair A. The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?. Trends in Pharmacological Sciences. June 2013, 34 (6): 332–339. PMID 23642658. doi:10.1016/j.tips.2013.04.001.
Baidya DK, Agarwal A, Khanna P, Arora MK. Pregabalin in acute and chronic pain. Journal of Anaesthesiology Clinical Pharmacology. July 2011, 27 (3): 307–314. PMC 3161452 . PMID 21897498. doi:10.4103/0970-9185.83672 .
Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Research. February 2007, 73 (2): 137–150 [October 19, 2020]. PMID 17126531. S2CID 54254671. doi:10.1016/j.eplepsyres.2006.09.008. （原始内容存档于October 23, 2020）.
Lauria-Horner BA, Pohl RB. Pregabalin: a new anxiolytic. Expert Opinion on Investigational Drugs. April 2003, 12 (4): 663–672. PMID 12665421. S2CID 36137322. doi:10.1517/13543784.12.4.663.
Desai A, Kherallah Y, Szabo C, Marawar R. Gabapentin or pregabalin induced myoclonus: A case series and literature review. Journal of Clinical Neuroscience. 2019-03, 61: 225–234. PMID 30381161. S2CID 53165515. doi:10.1016/j.jocn.2018.09.019.
Tanyıldız B, Kandemir B, Mangan MS, Tangılntız A, Göktaş E, Şimşek S. Bilateral Serous Macular Detachment After Attempted Suicide with Pregabalin. Turkish Journal of Ophthalmology. 2018-10, 48 (5): 254–257. PMC 6216534 . PMID 30405948. doi:10.4274/tjo.70923.
Yoo L, Matalon D, Hoffman RS, Goldfarb DS. Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure (PDF). American Journal of Kidney Diseases. 2009-12, 54 (6): 1127–1130 [October 19, 2020]. CiteSeerX 10.1.1.955.4223 . PMID 19493601. doi:10.1053/j.ajkd.2009.04.014. （原始内容存档于2022-04-12）.

psu.edu

citeseerx.ist.psu.edu

Yoo L, Matalon D, Hoffman RS, Goldfarb DS. Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure (PDF). American Journal of Kidney Diseases. 2009-12, 54 (6): 1127–1130 [October 19, 2020]. CiteSeerX 10.1.1.955.4223 . PMID 19493601. doi:10.1053/j.ajkd.2009.04.014. （原始内容存档于2022-04-12）.

scholar.google.com

Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, et al. Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits. European Journal of Pharmacology. September 2011, 667 (1–3): 80–90 [October 20, 2020]. PMID 21651903. doi:10.1016/j.ejphar.2011.05.054. （原始内容存档于October 21, 2020）.
Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Research. February 2007, 73 (2): 137–150 [October 19, 2020]. PMID 17126531. S2CID 54254671. doi:10.1016/j.eplepsyres.2006.09.008. （原始内容存档于October 23, 2020）.

semanticscholar.org

api.semanticscholar.org

Bryans JS, Wustrow DJ. 3-substituted GABA analogs with central nervous system activity: a review. Medicinal Research Reviews. March 1999, 19 (2): 149–177. PMID 10189176. S2CID 38496241. doi:10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B.
Calandre EP, Rico-Villademoros F, Slim M. Alpha₂delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Review of Neurotherapeutics. November 2016, 16 (11): 1263–1277. PMID 27345098. S2CID 33200190. doi:10.1080/14737175.2016.1202764.
Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Research. February 2007, 73 (2): 137–150 [October 19, 2020]. PMID 17126531. S2CID 54254671. doi:10.1016/j.eplepsyres.2006.09.008. （原始内容存档于October 23, 2020）.
Lauria-Horner BA, Pohl RB. Pregabalin: a new anxiolytic. Expert Opinion on Investigational Drugs. April 2003, 12 (4): 663–672. PMID 12665421. S2CID 36137322. doi:10.1517/13543784.12.4.663.
Desai A, Kherallah Y, Szabo C, Marawar R. Gabapentin or pregabalin induced myoclonus: A case series and literature review. Journal of Clinical Neuroscience. 2019-03, 61: 225–234. PMID 30381161. S2CID 53165515. doi:10.1016/j.jocn.2018.09.019.
Murphy NG, Mosher L. 79. Severe myoclonus from pregabalin (Lyrica) due to chronic renal insufficiency. Clinical Toxicology. 2008, 46 (7): 604. S2CID 218857181. doi:10.1080/15563650802255033 .

tga.gov.au

Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017. Therapeutic Goods Administration (TGA). 2022-06-21 [2024-03-30]. （原始内容存档于2023-07-06）.

web.archive.org

Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017. Therapeutic Goods Administration (TGA). 2022-06-21 [2024-03-30]. （原始内容存档于2023-07-06）.
Lyrica Summary of Product Characteristics (SmPC). (emc). 2023-02-27 [2023-12-21]. （原始内容存档于2023-12-21）.
Lyrica EPAR. European Medicines Agency (EMA). 2004-07-06 [2023-12-21]. （原始内容存档于2023-12-21）.
Summary of product characteristics (PDF). European Medicines Agency. 2013-03-06 [2013-05-06]. （原始内容存档 (PDF)于2018-09-16）.
Pharmacotherapy Update - Pregabalin (Lyrica®):Part I. [2016-02-22]. （原始内容存档于2017-02-27）.
Pregabalin. The American Society of Health-System Pharmacists. [2015-10-23]. （原始内容存档于2020-08-09）.
Lin GQ, You QD, Cheng JF (编). Chiral Drugs: Chemistry and Biological Action. John Wiley & Sons. August 8, 2011: 88 [August 17, 2016]. ISBN 9781118075630. （原始内容存档于April 25, 2022） –通过Google Books.
Li Z, Taylor CP, Weber M, Piechan J, Prior F, Bian F, et al. Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits. European Journal of Pharmacology. September 2011, 667 (1–3): 80–90 [October 20, 2020]. PMID 21651903. doi:10.1016/j.ejphar.2011.05.054. （原始内容存档于October 21, 2020）.
Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Research. February 2007, 73 (2): 137–150 [October 19, 2020]. PMID 17126531. S2CID 54254671. doi:10.1016/j.eplepsyres.2006.09.008. （原始内容存档于October 23, 2020）.
Yoo L, Matalon D, Hoffman RS, Goldfarb DS. Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure (PDF). American Journal of Kidney Diseases. 2009-12, 54 (6): 1127–1130 [October 19, 2020]. CiteSeerX 10.1.1.955.4223 . PMID 19493601. doi:10.1053/j.ajkd.2009.04.014. （原始内容存档于2022-04-12）.
禁毒科普丨普瑞巴林，危险的药物成瘾. 温州禁毒网. 2024-11-28 [2025-04-12]. （原始内容存档于2025-05-04）.

wenzhou.gov.cn

wzjd.wenzhou.gov.cn

禁毒科普丨普瑞巴林，危险的药物成瘾. 温州禁毒网. 2024-11-28 [2025-04-12]. （原始内容存档于2025-05-04）.